Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

8.1K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.1K
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

4.0K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
4.0K
Protein Networks02:26

Protein Networks

4.0K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.0K
Factors Influencing Drug Absorption: Disease States and Pharmacology01:25

Factors Influencing Drug Absorption: Disease States and Pharmacology

570
Multiple disease states can significantly influence the oral drug absorption process by affecting blood flow and the functionality of the gastrointestinal (GI) system. Various GI diseases, including conditions that alter GI motility, such as diarrhea, decreased acid secretions (achlorhydria), and infections, have been associated with reduced drug absorption.
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
570
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

13.6K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
13.6K
Drug Concentration Versus Time Correlation01:15

Drug Concentration Versus Time Correlation

877
The plasma drug concentration-time curve is a crucial tool in pharmacokinetics, representing the drug's concentration in plasma at different time intervals post-administration. This curve illustrates the drug's journey from absorption into the systemic circulation, distribution to body tissues, and eventual elimination through excretion or biotransformation.
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
877

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Pathway-Informed Deep Learning Models in Cancer Research: A Survey.

IEEE transactions on computational biology and bioinformatics·2025
Same author

Identify Modules Associated with Immunotherapy Response from Mouse Tumor Profiles for Stratifying Cancer Patients.

Interdisciplinary sciences, computational life sciences·2025
Same author

Early myeloid-derived suppressor cells accelerate epithelial-mesenchymal transition by downregulating ARID1A in luminal A breast cancer.

Frontiers in bioengineering and biotechnology·2022
Same author

Prediction performance of twelve tumor mutation burden panels in melanoma and non-small cell lung cancer.

Critical reviews in oncology/hematology·2021
Same author

A network-based pathway-extending approach using DNA methylation and gene expression data to identify altered pathways.

Scientific reports·2019
Same author

Dual functional dinuclear platinum complex with selective reactivity towards c-myc G-quadruplex.

Scientific reports·2018

Related Experiment Video

Updated: Jul 20, 2025

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
07:35

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports

Published on: October 13, 2023

1.7K

Predicting Drug-Disease Associations Through Similarity Network Fusion and Multi-View Feature Projection

Shiming Wang, Jie Li, Dong Wang

    IEEE Journal of Biomedical and Health Informatics
    |August 1, 2023
    PubMed
    Summary

    This study introduces a novel computational model for predicting drug-disease associations (DDAs) by integrating diverse data. The model effectively identifies potential new DDAs, advancing drug development efficiency.

    More Related Videos

    Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
    08:51

    Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts

    Published on: September 20, 2024

    1.3K
    Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
    14:27

    Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

    Published on: June 26, 2013

    15.7K

    Related Experiment Videos

    Last Updated: Jul 20, 2025

    A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
    07:35

    A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports

    Published on: October 13, 2023

    1.7K
    Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
    08:51

    Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts

    Published on: September 20, 2024

    1.3K
    Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
    14:27

    Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

    Published on: June 26, 2013

    15.7K

    Area of Science:

    • Computational biology
    • Pharmacogenomics
    • Bioinformatics

    Background:

    • Drug-disease association (DDA) prediction is crucial for efficient drug development.
    • Existing computational methods often overlook potential associations in unconfirmed pairs.
    • Integrating multiple data resources into heterogeneous networks is a common approach.

    Purpose of the Study:

    • To propose a novel computational model for predicting new drug-disease associations (DDAs).
    • To address the limitation of existing methods in considering unconfirmed drug-related or disease-related pairs.
    • To enhance the accuracy and efficiency of DDA prediction in drug development.

    Main Methods:

    • Construction of a heterogeneous network with drugs, targets, cell lines, and diseases.
    • Application of an updating and merging-based similarity network fusion (UM-SF) method.
    • Utilizing an intermediate layer-mediated multi-view feature projection representation (IM-FP) method for DDA scoring.

    Main Results:

    • The proposed model demonstrates effectiveness through comparative experiments.
    • 10-fold cross-validation shows superior performance on AUROC and AUPR metrics compared to state-of-the-art models.
    • The model successfully predicted 107 novel high-ranked drug-disease associations.

    Conclusions:

    • The novel computational model significantly improves the prediction of drug-disease associations.
    • The UM-SF and IM-FP methods offer innovative solutions for integrating diverse biological data.
    • This approach holds promise for accelerating drug discovery and development.